GlassScriptPhysician profile
Maria A Gonzalez
NPI 1265725238
$2,712.39
in general payments reported to CMS, 2019-2025
12 companies · $67.27 in 2025
The $67.27 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $697 · 2021: $636 · 2022: $595 · 2023: $190 · 2024: $89.39 · 2025: $67.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,153.99 | 2021-2022 | |
| Allergan, INC. | $759.37 | 2019-2020 | |
| Cleerly, INC. | $142.26 | 2023 | Cleerly Labs |
| Abbott Laboratories | $140.63 | 2019-2025 | Assurity |
| Glaxosmithkline, LLC. | $134.79 | 2024-2025 | Nucala, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2020 | |
| Intersect Ent, INC. | $115.31 | 2019 | |
| Pfizer INC. | $58.39 | 2021-2022 | |
| Argenx US, INC. | $27.75 | 2023 | Vyvgart |
| Novo Nordisk INC | $20.48 | 2023 | Wegovy |
| Lilly USA, LLC | $18.57 | 2021 | |
| Phadia US INC. | $15.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.